Page 188 - Demo

Chapter 7186 Fig. 4: (a) Lattice structure before bone application (black arrow).(b) Lattice structure with mixture of bone and fibrin sealant (black arrow).This excess volume of UHMWPE resulted from using the human type of fossa UHMWPE design, in which there is to reckon with a lower total muscle mass of the lateral pterygoid muscle, resulting in less spherical obstruction. As we were not able to completely segment the LPM during the design process of the implant, this led to a slight underestimation of the total muscle volume. All UHMWPE parts were altered in such a fashion that it did not affect the articulating surface, nor that the LPM experienced any obstruction after correction.The articular capsule and soft tissues were closed in multiple layers and a compressive bandage was placed for one week. Per-operative pain control was achieved using buprenorphine (6 µg/kg) administered via the intravenous route.Nikolas de Meurechy NW.indd 186 05-06-2024 10:14